NCT04162353: BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma |
|
|
| Recruiting | 1 | 12 | RoW | BCMA-CD19 cCAR T cells | iCell Gene Therapeutics, iCAR Bio Therapeutics Ltd., Peking University Shenzhen Hospital | Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Plasmacytoid; Lymphoma | 09/21 | 09/21 | | |
NCT05474885: BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE) |
|
|
| Recruiting | 1 | 15 | RoW | BCMA-CD19 cCAR T cells | iCell Gene Therapeutics, iCAR Bio Therapeutics Ltd. China | Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) | 04/25 | 04/25 | | |
